JP2022539148A5 - - Google Patents

Info

Publication number
JP2022539148A5
JP2022539148A5 JP2021577391A JP2021577391A JP2022539148A5 JP 2022539148 A5 JP2022539148 A5 JP 2022539148A5 JP 2021577391 A JP2021577391 A JP 2021577391A JP 2021577391 A JP2021577391 A JP 2021577391A JP 2022539148 A5 JP2022539148 A5 JP 2022539148A5
Authority
JP
Japan
Application number
JP2021577391A
Other languages
Japanese (ja)
Other versions
JPWO2020264411A5 (https=
JP2022539148A (ja
JP7539420B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/039971 external-priority patent/WO2020264411A1/en
Publication of JP2022539148A publication Critical patent/JP2022539148A/ja
Publication of JPWO2020264411A5 publication Critical patent/JPWO2020264411A5/ja
Publication of JP2022539148A5 publication Critical patent/JP2022539148A5/ja
Application granted granted Critical
Publication of JP7539420B2 publication Critical patent/JP7539420B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577391A 2019-06-28 2020-06-26 アデノ随伴ウイルスの精製方法 Active JP7539420B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962868282P 2019-06-28 2019-06-28
US62/868,282 2019-06-28
PCT/US2020/039971 WO2020264411A1 (en) 2019-06-28 2020-06-26 Adeno-associated virus purification methods

Publications (4)

Publication Number Publication Date
JP2022539148A JP2022539148A (ja) 2022-09-07
JPWO2020264411A5 JPWO2020264411A5 (https=) 2023-05-25
JP2022539148A5 true JP2022539148A5 (https=) 2023-05-25
JP7539420B2 JP7539420B2 (ja) 2024-08-23

Family

ID=74061311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577391A Active JP7539420B2 (ja) 2019-06-28 2020-06-26 アデノ随伴ウイルスの精製方法

Country Status (6)

Country Link
US (1) US20220267796A1 (https=)
EP (1) EP3990031A4 (https=)
JP (1) JP7539420B2 (https=)
CN (1) CN114173827B (https=)
TW (1) TWI886135B (https=)
WO (1) WO2020264411A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201628649A (zh) 2014-10-09 2016-08-16 再生元醫藥公司 減少醫藥調配物中微可見顆粒之方法
KR102369014B1 (ko) 2016-08-16 2022-03-02 리제너론 파아마슈티컬스, 인크. 혼합물로부터 개별 항체들을 정량하는 방법
EA201990986A1 (ru) 2016-10-25 2019-09-30 Ридженерон Фармасьютикалз, Инк. Способы и системы анализа хроматографических данных
WO2019060062A1 (en) 2017-09-19 2019-03-28 Regeneron Pharmaceuticals Inc. METHODS OF REDUCING PARTICLE FORMATION AND COMPOSITIONS FORMED THEREFROM
TWI853823B (zh) 2018-07-02 2024-09-01 美商里珍納龍藥品有限公司 自混合物製備多肽之系統及方法
EA202192422A1 (ru) 2019-03-05 2021-12-09 Ридженерон Фармасьютикалз, Инк. Человеческий сывороточный альбумин в составах
CN117716234A (zh) * 2022-01-03 2024-03-15 科尔仕公司 用于从样本中分离阴电性低密度脂蛋白的生物试剂套组、试剂溶液以及从样本中分离阴电性低密度脂蛋白的方法
US20230303983A1 (en) * 2022-03-28 2023-09-28 President And Fellows Of Harvard College High efficiency purification of divergent aav serotypes using aavx affinity chromatography
WO2023189652A1 (ja) * 2022-03-29 2023-10-05 株式会社カネカ アデノ随伴ウイルスの製造方法
CA3247416A1 (en) * 2022-04-08 2023-10-12 Csl Behring Ag Methods of sanitizing and/or regenerating a chromatography medium
WO2024252024A1 (en) * 2023-06-09 2024-12-12 Sartorius Bia Separations D.O.O. A method of enhanced separation of full adeno-associated virus (aav) capsids
EP4731755A2 (en) * 2023-06-23 2026-04-29 Ultragenyx Pharmaceutical Inc. Compositions and methods for reducing host cell proteins in recombinant adeno-associated virus preparations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732129B1 (en) * 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
KR100912362B1 (ko) * 1998-02-17 2009-08-19 쉐링 코포레이션 바이러스 제제의 정제방법
US6593123B1 (en) * 2000-08-07 2003-07-15 Avigen, Inc. Large-scale recombinant adeno-associated virus (rAAV) production and purification
CA2496918A1 (en) * 2002-08-28 2004-03-11 Introgen Therapeutics Inc. Chromatographic methods for adenovirus purification
NZ548495A (en) * 2004-02-23 2009-05-31 Crucell Holland Bv Virus purification methods
WO2006011580A1 (ja) * 2004-07-27 2006-02-02 Genomidea, Inc. ウイルスエンベロープの精製方法
WO2009123348A1 (ja) * 2008-03-31 2009-10-08 日本たばこ産業株式会社 ウイルス濃縮法
EP3054007A1 (en) * 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
BR112018070256A2 (pt) * 2016-03-31 2019-01-29 Spark Therapeutics, Inc. processo de fabricação de raav totalmente escalável à base de colunas
SG11202006232SA (en) * 2017-12-29 2020-07-29 Baxalta Inc Adeno-associated virus purification methods

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022539148A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021015450A8 (https=)
BR102021014044A2 (https=)
BR102021013929A2 (https=)
BR102021012230A2 (https=)